It may be possible to predict progression of type 2 diabetes in kids with prediabetes through a few important screening tests notably A1c plus nonfasting glucose and possibly stop it in its tracks.
The number of US employers who cover obesity medications, including Wegovy from Novo Nordisk that belongs to a class of GLP-1 drugs, could nearly double next year, according to a survey.